Clinical Trials Browser

Carcinoid Tumor, Serotonin Syndrome

NCT05064514 2025-05-01

TRICAR

Phase NA Active not recruiting

15 enrolled

Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Tricuspid Valve Insufficiency, Serotonin Syndrome

NCT03453489 2025-04-10

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

Phase 2 Completed

4 enrolled 7 charts

Serotonin Syndrome

NCT04713202 2023-02-10

NET-PACS

Phase 2 Withdrawn

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT03722511 2022-11-03

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Phase 2 Completed

10 enrolled

EndocrineNET

Diarrhea, Neuroendocrine Tumors, Serotonin Syndrome

NCT04776876 2021-09-29

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Phase 2 Withdrawn

Serotonin Syndrome

NCT04073017 2021-05-21

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

Phase NA Terminated

11 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT04039516 2020-08-04

CHARRT

Phase 2 Unknown

20 enrolled

Endocrine

Carcinoid Heart Disease, Carcinoid Tumor, Serotonin Syndrome

NCT04140409 2019-10-25

SCIROCCO

Phase 4 Terminated

10 enrolled

EndocrineNET

Neuroendocrine Tumors, Serotonin Syndrome

NCT01172717 2013-07-26

Study of Panitumumab in the Treatment of Carcinoid Syndrome

Phase 2 Withdrawn

Endocrine

Carcinoid Tumor, Serotonin Syndrome

Clinical Trials

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

TRICAR

AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm

NET-PACS

Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs

Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome

Enterade in Carcinoid/Non-Carcinoid Syndrome Neuroendocrine Tumor Patients With Quality of Life Limiting Bowel Frequency

CHARRT

SCIROCCO

Study of Panitumumab in the Treatment of Carcinoid Syndrome